Scandinavian Cohort Study for Optimal Use of Portal Vein Embolization
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 300
- 试验地点
- 1
- 主要终点
- Future liver remnant hypertrophy
研究概览
简要总结
Several aspects on the use of portal vein embolization (PVE) are poorly studied and todays recommendations are based on low-grade evidence. In this Scandinavian multicenter cohort study we will study some of the controversial aspects on the use of PVE to try to provide clearer answers on its optimal use. Six tertiary university hospital hepatobiliary units in Sweden, Norway and Denmark participate and contribute with all PVE procedures performed at their units during the study period. We will then study several aspects PVE technique in relation to induced hypertrophy and surgical outcome.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Right-sided PVE
排除标准
- •Left-sided PVE
结局指标
主要结局
Future liver remnant hypertrophy
时间窗: Based on radiology around 4 weeks before and after intervention
Increase in future liver remnant, (%)
次要结局
- Effect of sarcopenia on hypertrophy(Based on radiology around 4 weeks before and after intervention)
- Effect of segment 4 embolization on hypertrophy(Based on radiology around 4 weeks before and after intervention)
- Effect of hyperbilirubinemia on hypertrophy(Based on radiology around 4 weeks before and after intervention)
研究者
Ernesto Sparrelid
Acting Head of HPB Surgery, MD PhD
Karolinska University Hospital